O-Ring seals are commonly used in the pharmaceutical industry to ensure proper sealing and containment of fluids in various applications, including USP 661.26 compliant seals. These seals are designed to meet the stringent requirements outlined in the United States Pharmacopeia (USP) Chapter 661.26 for elastomeric closures for injections.

USP 661.26 sets forth guidelines for the testing and evaluation of elastomeric closures used in pharmaceutical packaging, including O-Ring seals. These guidelines include requirements for physical and chemical properties, extractables and leachables, and biocompatibility to ensure the safety and efficacy of pharmaceutical products.

When selecting O-Ring seals for USP 661.26 compliant applications, it is important to choose materials that meet the specific requirements outlined in the standard. This includes selecting materials that are compatible with the contents of the pharmaceutical product and have been tested for biocompatibility and chemical compatibility.

In addition to material compatibility, proper design and installation of O-Ring seals are essential to ensure effective sealing and containment. This includes ensuring proper groove design, compression, and installation techniques to prevent leakage and contamination of the pharmaceutical product.

Overall, O-Ring seals play a critical role in ensuring the integrity and safety of pharmaceutical packaging in compliance with USP 661.26 standards. By selecting the right materials, following proper installation procedures, and conducting regular testing and evaluation, pharmaceutical manufacturers can ensure the reliability and performance of O-Ring seals in their applications.